|1.||Guzmán, Manuel: 27 articles (01/2015 - 04/2002)|
|2.||Velasco, Guillermo: 19 articles (01/2016 - 04/2002)|
|3.||Fernández-Ruiz, Javier: 18 articles (10/2015 - 05/2003)|
|4.||Mechoulam, Raphael: 17 articles (08/2011 - 02/2002)|
|5.||Lorente, Mar: 12 articles (01/2016 - 07/2006)|
|6.||Baker, David: 11 articles (08/2015 - 04/2003)|
|7.||Pryce, Gareth: 11 articles (08/2015 - 04/2003)|
|8.||Carracedo, Arkaitz: 10 articles (10/2015 - 06/2004)|
|9.||Ramer, Robert: 10 articles (01/2015 - 12/2004)|
|10.||Hinz, Burkhard: 10 articles (01/2015 - 12/2004)|
04/01/2015 - "They also indicated a need for guidelines or algorithms that included cannabinoid use as well as more studies about the efficacy and safety of cannabinoids for the management of chronic noncancer pain. "
06/18/2008 - "Many recent clinical studies investigating the role of cannabinoids in various pain syndromes demonstrated overall positive results. "
12/24/2010 - "In contrast, in chronic pain and (painful) spasticity, an increasing number of randomized, double-blind, placebo-controlled studies have shown the efficacy of cannabinoids, which is combined with a narrow therapeutic index. "
01/01/2008 - "Data from large, well-controlled studies show that cannabinoids are moderately effective in reducing chronic pain and that side effects are comparable to existing treatments, suggesting that cannabinoids can play a useful role in the management of chronic pain. "
11/01/2007 - "Based on our observations, combined administration of cannabinoids with COX inhibitors may hold a therapeutic promise in the treatment of inflammatory TMJ pain."
|2.||Neuralgia (Stump Neuralgia)
04/01/2004 - "Although cannabinoids have anti-hyperalgesic effects in animal models of nerve injury, there are currently very few prospective trials of the efficacy of cannabinoids in neuropathic pain in humans. "
10/01/2014 - "Exogenous cannabinoids have been demonstrated to be effective in a range of experimental neuropathic pain models, and there is mounting evidence for therapeutic use in human neuropathic pain conditions. "
09/01/2003 - "Exogenous cannabinoids are effective in attenuating neuropathic pain behaviors induced by peripheral nerve injury, but the mechanisms of their effectiveness remain unclear. "
04/01/2004 - "Are oral cannabinoids safe and effective in refractory neuropathic pain?"
11/01/2012 - "Clinical trials, both with synthetic or plant-derived cannabinoids, have demonstrated clinical efficacy of cannabinoids for the treatment of spasticity, neuropathic pain and bladder dysfunction. "
12/15/2006 - "Many reports have shown that cannabinoids might be beneficial in the symptomatic treatment of multiple sclerosis (MS). "
09/01/2001 - "Data, initially anecdotal, but recently supported on more solid experimental evidence, suggest that cannabinoids might be beneficial in the treatment of some of the symptoms of multiple sclerosis (MS). "
08/01/2004 - "Although cannabinoid treatment of multiple sclerosis symptoms has been shown to be both well tolerated and effective in a number of subjective tests in several small-scale clinical trials, objective measures demonstrating the efficacy of cannabinoids are still lacking. "
05/01/2005 - "The evidence for the therapeutic efficacy of cannabinoids in the treatment of multiple sclerosis (MS) is increasing but is not as yet convincing. "
05/19/2015 - "Clinical trials investigating the analgesic efficacy of cannabinoids in multiple sclerosis have yielded mixed results, possibly due to psychotropic side effects mediated by cannabinoid CB1 receptors. "
08/01/2012 - "Overall, the results reported here suggest that the exploration of molecular mechanisms induced by cannabinoids in cancer cells can contribute to the development of safe and effective treatments in cancer therapy."
06/01/2004 - "In cancer patients, cannabinoids proved more effective than placebo but less than gestagenes. "
01/01/2001 - "For all the present and probable future uses, pure cannabinoids, administered orally, rectally or parenterally, have been shown to be effective, and they are free of the risks of chronic inflammatory disease of the airways and upper respiratory cancer that are associated with the smoking of crude cannabis. "
01/01/2015 - "Regarding the underlying antimetastatic mechanism, several studies revealed cannabinoids to alter the gene expression of cancer cells toward a less-aggressive phenotype and to modulate their secretomic profile. "
09/15/2014 - "In the present study the impact of cannabinoids on potential tumor-to-endothelial cell communication conferring anti-angiogenesis was studied. "
01/01/2002 - "The present study indicates that: 1) 2-AG is an efficacious endogenous emetogenic cannabinoid involved in vomiting circuits, 2) the emetic action of 2-AG and the antiemetic effects of tested cannabinoids are mediated via CB(1) receptors, and 3) the emetic effects of 2-AG occur in lower doses relative to its locomotor suppressant actions."
02/01/2001 - "The present study investigates the mechanism of antiemetic action of cannabinoids in an established animal model of emesis, the least shew (Cryptotis parva). "
08/01/2011 - "The anti-emetic effect of cannabinoids has been shown across a wide variety of animals that are capable of vomiting in response to a toxic challenge. "
08/01/2008 - "The effect of cannabinoids on motion-induced emesis is unknown. "
06/01/2007 - "Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew."
|1.||Opioid Analgesics (Opioids)
|3.||Cannabinoid Receptors (Cannabinoid Receptor)
|4.||Analgesics (Analgesic Drugs)
|5.||CB1 Cannabinoid Receptor (CB1 Receptor)
|6.||Serotonin (5 Hydroxytryptamine)
|1.||Drug Therapy (Chemotherapy)